Open Journal of Medical Imaging

Volume 3, Issue 3 (September 2013)

ISSN Print: 2164-2788   ISSN Online: 2164-2796

Google-based Impact Factor: 0.8  Citations  

Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease (CAD) in Patients with Angina Pectoris

HTML  Download Download as PDF (Size: 85KB)  PP. 97-101  
DOI: 10.4236/ojmi.2013.33015    4,426 Downloads   7,787 Views  Citations

ABSTRACT

Background: Prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing in Iranian population. The aim of this study was the investigation of association between nonalcoholic fatty liver disease (NAFLD) and coronary artery disease (CAD) in patients with angina pectoris. Methods: 82 patients with confirmed CAD by coronary angiography and 82 individuals with normal coronary angiography, as the control group, were selected. Hepatic ultrasound scanning was performed in all the subjects to determinate the NAFLD. Data were analyzed by SPSS software and independent T-test and Chi-square tests. Results: Findings gathered from the patients with angina pectoris showed that the prevalence of NAFLD in CAD patients was higher than the control group. Grade of fatty liver and the portal vein size in CAD patients were significantly more than the control group. Conclusion: NAFLD is a risk factor of CAD in the angina pectoris patients. Increase in the prevalence of NAFLD can lead to the increase in cardiovascular diseases.

Share and Cite:

Adibi, A. , Jaberzadeh-Ansari, M. , Dalili, A. , Omidifar, N. and Sadeghi, M. (2013) Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease (CAD) in Patients with Angina Pectoris. Open Journal of Medical Imaging, 3, 97-101. doi: 10.4236/ojmi.2013.33015.

Cited by

[1] Assessment of hepatic steatosis by computed tomography and its relation with coronary artery disease
Menoufia Medical Journal, 2022
[2] Screening, Characterization and Production of Thermostable Alpha-Amylase Produced by a Novel Thermophilic Bacillus megaterium Isolated from Pediatric …
2020
[3] A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver …
2020
[4] Evaluation of Relationship between Nonalcoholic Fatty Liver and Coronary Artery Disease Severity by Multidetector Computed Tomography
2019
[5] Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind …
2018
[6] The effects of green cardamom supplementation on blood glucose, lipids profile, oxidative stress, sirtuin-1 and irisin in type 2 diabetic patients: a study …
2018
[7] The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial
Trials, 2017
[8] Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol
BMJ open, 2017
[9] Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver …
2017
[10] Milad Daneshi-Maskooni1, Seyed Ali Keshavarz2, Siavash Mansouri3, Mostafa Qorbani4, Seyed Moayed Alavian5
2017
[11] The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver …
Maskooni, SA Keshavarz, S Mansouri… - Trials, 2017
[12] 冠心病并发非酒精性脂肪肝中脂联素肿瘤细胞因子-α 及胰岛素抵抗的表达
河北医学, 2015
[13] To Determine the Frequency of Peripheral Vascular Disease In Non-alcoholic Fatty Liver Disease
A Hassan, S Waheed

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.